Detailed Information on Publication Record
2016
Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-array based comparative genomic hybridization in human myeloma cell line
MIKULÁŠOVÁ, Aneta, Jan SMETANA, Markéta WAYHELOVÁ, Helena JANYŠKOVÁ, Samuel Adeyinka OKUBOTE et. al.Basic information
Original name
Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-array based comparative genomic hybridization in human myeloma cell line
Authors
MIKULÁŠOVÁ, Aneta (203 Czech Republic, belonging to the institution), Jan SMETANA (203 Czech Republic, belonging to the institution), Markéta WAYHELOVÁ (203 Czech Republic, belonging to the institution), Helena JANYŠKOVÁ (203 Czech Republic, belonging to the institution), Samuel Adeyinka OKUBOTE (566 Nigeria, belonging to the institution), Roman HÁJEK (203 Czech Republic) and Petr KUGLÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
International Journal of Clinical and Experimental Pathology, 2016, 1936-2625
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.706
RIV identification code
RIV/00216224:14310/16:00088952
Organization unit
Faculty of Science
UT WoS
000381729200036
Keywords in English
whole genome amplification; array-comparative genomic hybridization; copy-number changes
Tags
International impact, Reviewed
Změněno: 26/4/2017 23:13, Ing. Andrea Mikešková
Abstract
V originále
Whole genome amplification (WGA) is an approach designed to overcome small amounts of DNA for genome-wide genetic tests used in many clinical applications. Various strategies of WGA have been developed; however, none of them can guarantee the absence of amplification bias. In this study, a total of 4 multiple displacement amplification (MDA)-based and 2 PCR-based WGA kits were compared in their effect on segmental copy-number (CN) changes and copy-number neutral loss of heterozygosity (cnnLOH) detection by 3 microarray platforms: CGH/4×44 K (Agilent), CGH+SNP/4×180 K (Agilent) and CGH+SNP/4×180 K (OGT). Genomic imbalances-rich myeloma cell line U266 was used as material. The main outcomes are as follows: 1) MDA-based WGAs showed higher tendency to generate false positive imbalances in contrast to PCR-based WGAs with higher risk of false negativity; 2) the specific risk of false positivity and/or negativity increased with decreasing CN segments size; 3) single-cell WGAs showed significantly worse effect on results in comparison to WGAs with nanogram level of DNA as input; 4) PCR-based WGAs were incompatible with cnnLOH analysis based on SNP in restriction digestion sites and also showed higher risk of cnnLOH false negativity when combined with analysis based on simple hybridization. In conclusion, the results of this study help to choose WGA according to individual user requirements and options. Moreover, we have shown a strategy to verify and validate segmental CN changes detection by DNA array protocol including any WGA for any purpose to attain the highest efficiency without an unnecessary WGA bias.
Links
NT13492, research and development project |
|